Stocks and Investing
Stocks and Investing
Fri, October 7, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, October 6, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Richard Law Initiated (VERV) at Hold and Held Target at $48 on, Oct 6th, 2022
Richard Law of Credit Suisse, Initiated "Verve Therapeutics, Inc." (VERV) at Hold and Held Target at $48 on, Oct 6th, 2022.
Richard has made no other calls on VERV in the last 4 months.
There are 2 other peers that have a rating on VERV. Out of the 2 peers that are also analyzing VERV, 0 agree with Richard's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Richard
- Dae Gon Ha of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $56 on, Thursday, August 25th, 2022
- Kostas Biliouris of "BMO Capital" Maintained at Buy with Increased Target to $62 on, Monday, July 18th, 2022
Contributing Sources